RavenQuest Accelerates National Growth Strategy, Acquires Toronto Area Licensed Producer
February 26th, 2018
Exclusive, News, Top News
RavenQuest BioMed Inc. (CSE: RQB) is a great example of a diversified cannabis company with its four pillars approach to the industry. Recent developments have greatly accelerated the company’s progress on a number of fronts. With near-term licensed production expected to come online to coincide with the coming federal legalization of adult recreational cannabis use, investors may want to take a closer look at the stock.
Four Pillars Approach
RavenQuest BioMed has developed a four pillars approach to the cannabis industry to generate both near- and long-term value for shareholders.
- Indigenous Peoples Traction – The company provides a turnkey solution for the production and sale of cannabis on sovereign land. Under the guidance of Bill Robinson, a 34-year veteran of the Royal Canadian Mounted Police, the company has already identified and engaged with an impressive list of prospective partners. RavenQuest was recently selected as the sole industry participant at recent province-wide meetings on Indigenous participation in the cannabis industry. Over 120 leaders from Indigenous communities across the Province of Saskatchewan were in attendance with extremely positive feedback. A significant number of those in attendance expressed immediate interest in further discussion.
- Production and Sale of Cannabis (Investment Division) – In addition to 100% ownership in late-stage applicant, Alberta Green Biotech, RavenQuest also just announced a binding letter of intent to acquire an existing licensed producer in Ontario. Both deals are discussed in detail below.
- Research and Development – The company’s partnership with top-ranked McGill University targets maximized flower production, cultivar recognition and stabilization of the cannabis plant. The plant breeders’ rights that result from the research can be applied to its own operations and sold to other licensed producers industrywide.
- Management Services – Even prior to full legalization and production begins, RavenQuest is cash-flow positive, unique for an early-stage growth company and reassuring to investors. The company has already provided consulting services to eleven licensed producers and helped them navigate the complex and demanding Health Canada licensing process. With a steady pipeline of management service contracts, the company generates revenue right now while building new partnerships. The services division also acts as a natural source of deal flow for the Investment Division, as it is likely that many existing services clients will become friendly acquisitions when RavenQuest sees a strategic fit and opportunity.
The combination of near-term revenue and long-term potential sets the company apart from competitors in the cannabis industry.
Mergers & Acquisitions
In late January, RavenQuest BioMed announced a binding letter of intent to purchase Bloomera, a licensed producer of medical cannabis located in the Greater Toronto Area. Under the terms of the LOI, the company agreed to acquire all of the outstanding share capital of Bloomera.
Bloomera holds an active Health Canada License to Cultivate with up to 4,000,000 grams of production capacity. More importantly, the acquisition accelerates the company’s growth strategy by at least six months and opens the door to a much faster growth trajectory moving forward. The Bloomera facility is strategically located, providing access to Ontario’s 13 million residents and largest population centre of 6.4 million in Toronto alone. This is an important provincial presence because cannabis distribution will be controlled by central distributors in each of Canada’s provinces.
RavenQuest’s new central Canadian acquisition broadens the company’s national reach and compliments its existing presence in western Canada. Alberta Green Biotech Inc., an aspiring licensed producer based in Edmonton, will have capacity of about 7,000,000 grams per year. Facility construction is expected to be completed and ready to produce by mid-2018 to coincide with federal legalization of recreational marijuana, creating a near-term catalyst for shareholders.
Combined, the two deals give RavenQuest geographic diversification across Canada, including a licensed presence in the country’s most populous province, Ontario.
RavenQuest BioMed Inc. (CSE: RQB) represents a compelling investment opportunity in Canada’s burgeoning cannabis industry. With a four pillar approach to the market, the company offers both near- and long-term potential to investors. Its acquisition of two cultivation properties also opens the door to near-term cultivation and production opportunities later this year. Investors interested in the space may want to take a closer look at the company.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please see our disclaimer below and follow the link to view our full disclosure outlining compensation: https://www.cannabisfn.com/legal-disclaimer/
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.